Lilly Discloses First-in-Class, Interim Phase 2 Data in Pediatric Patients and New Analysis from Phase 3 Program in Adult Patients for Mirikizumab in Ulcerative Colitis

Media coverage

• Title	Lilly Discloses First-in-Class, Interim Phase 2 Data in Pediatric Patients and New Analysis from Phase 3 Program in Adult Patients for Mirikizumab in Ulcerative Colitis
  Media name/outlet	Drugs.com
  Country/Territory	United States
  Date	15/05/23
  URL	https://www.drugs.com/clinical_trials/lilly-discloses-first-class-interim-phase-2-data-pediatric-patients-new-analysis-phase-3-program-20786.html
  Persons	Marla Dubinsky, Todd Rubin